Incidental Mutation 'R3766:Brf2'
ID 274714
Institutional Source Beutler Lab
Gene Symbol Brf2
Ensembl Gene ENSMUSG00000031487
Gene Name BRF2, RNA polymerase III transcription initiation factor 50kDa subunit
Synonyms 5730512K07Rik, TFIIIB50, 2700059M06Rik, BRFU
MMRRC Submission 040743-MU
Accession Numbers
Essential gene? Probably essential (E-score: 0.957) question?
Stock # R3766 (G1)
Quality Score 225
Status Validated
Chromosome 8
Chromosomal Location 27613392-27618708 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) G to T at 27614496 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Threonine to Asparagine at position 230 (T230N)
Ref Sequence ENSEMBL: ENSMUSP00000033877 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000033876] [ENSMUST00000033877] [ENSMUST00000178514] [ENSMUST00000179351] [ENSMUST00000209770] [ENSMUST00000210552] [ENSMUST00000211151]
AlphaFold no structure available at present
Predicted Effect probably benign
Transcript: ENSMUST00000033876
SMART Domains Protein: ENSMUSP00000033876
Gene: ENSMUSG00000031486

DomainStartEndE-ValueType
signal peptide 1 33 N/A INTRINSIC
LRR 82 106 1.06e2 SMART
LRR_TYP 107 130 2.71e-2 SMART
LRR_TYP 131 154 1.28e-3 SMART
LRR 155 178 7.38e1 SMART
LRRCT 190 240 4.63e-6 SMART
IG 253 346 3.49e-3 SMART
low complexity region 629 639 N/A INTRINSIC
low complexity region 663 674 N/A INTRINSIC
Pfam:GPS 709 750 1.1e-7 PFAM
Pfam:7tm_2 770 990 5.3e-13 PFAM
transmembrane domain 1016 1038 N/A INTRINSIC
transmembrane domain 1045 1064 N/A INTRINSIC
low complexity region 1075 1095 N/A INTRINSIC
low complexity region 1110 1129 N/A INTRINSIC
Predicted Effect possibly damaging
Transcript: ENSMUST00000033877
AA Change: T230N

PolyPhen 2 Score 0.499 (Sensitivity: 0.88; Specificity: 0.90)
SMART Domains Protein: ENSMUSP00000033877
Gene: ENSMUSG00000031487
AA Change: T230N

DomainStartEndE-ValueType
Pfam:TF_Zn_Ribbon 6 42 5.7e-11 PFAM
SCOP:d1aisb1 73 167 1e-12 SMART
Blast:CYCLIN 74 158 2e-51 BLAST
Blast:CYCLIN 171 275 6e-61 BLAST
low complexity region 322 336 N/A INTRINSIC
low complexity region 355 367 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000178514
SMART Domains Protein: ENSMUSP00000136277
Gene: ENSMUSG00000031486

DomainStartEndE-ValueType
signal peptide 1 33 N/A INTRINSIC
LRR 82 106 4.4e-1 SMART
LRR_TYP 107 130 1.1e-4 SMART
LRR_TYP 131 154 5.3e-6 SMART
LRR 155 178 3.1e-1 SMART
LRRCT 190 240 2.2e-8 SMART
IG 253 346 1.4e-5 SMART
HormR 349 426 1.8e-4 SMART
Pfam:7tm_2 554 775 3.2e-11 PFAM
transmembrane domain 801 823 N/A INTRINSIC
transmembrane domain 830 849 N/A INTRINSIC
low complexity region 860 880 N/A INTRINSIC
low complexity region 895 914 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000179207
Predicted Effect probably benign
Transcript: ENSMUST00000179351
SMART Domains Protein: ENSMUSP00000137457
Gene: ENSMUSG00000031486

DomainStartEndE-ValueType
Pfam:GPS 5 49 4.5e-11 PFAM
transmembrane domain 67 89 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000209770
Predicted Effect noncoding transcript
Transcript: ENSMUST00000210230
Predicted Effect probably benign
Transcript: ENSMUST00000210552
Predicted Effect probably benign
Transcript: ENSMUST00000211151
Predicted Effect probably benign
Transcript: ENSMUST00000211236
Predicted Effect noncoding transcript
Transcript: ENSMUST00000210590
Meta Mutation Damage Score 0.1739 question?
Coding Region Coverage
  • 1x: 99.2%
  • 3x: 98.6%
  • 10x: 97.4%
  • 20x: 95.4%
Validation Efficiency 98% (41/42)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes one of the multiple subunits of the RNA polymerase III transcription factor complex required for transcription of genes with promoter elements upstream of the initiation site. The product of this gene, a TFIIB-like factor, is directly recruited to the TATA-box of polymerase III small nuclear RNA gene promoters through its interaction with the TATA-binding protein. [provided by RefSeq, Jul 2008]
Allele List at MGI
Other mutations in this stock
Total: 42 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Aacs C T 5: 125,583,326 (GRCm39) T294M probably damaging Het
Ccne2 A G 4: 11,199,293 (GRCm39) probably benign Het
Crbn T C 6: 106,771,987 (GRCm39) K106E possibly damaging Het
Cttnbp2nl G A 3: 104,912,117 (GRCm39) T589I probably benign Het
Dock10 A G 1: 80,514,643 (GRCm39) S1091P probably damaging Het
Fh1 A G 1: 175,442,316 (GRCm39) V178A probably damaging Het
Fndc1 A G 17: 8,003,253 (GRCm39) S111P probably damaging Het
Frk A G 10: 34,360,001 (GRCm39) M1V probably null Het
Gm29394 C T 15: 57,912,024 (GRCm39) probably benign Het
Herc2 A G 7: 55,813,572 (GRCm39) D2601G probably damaging Het
Hspa13 T C 16: 75,561,974 (GRCm39) D75G probably benign Het
Itgav T C 2: 83,632,229 (GRCm39) probably null Het
Kif6 A T 17: 50,065,671 (GRCm39) probably benign Het
Lypla1 G A 1: 4,911,201 (GRCm39) R104Q probably benign Het
Map1b T C 13: 99,570,595 (GRCm39) K709E unknown Het
Or52l1 A T 7: 104,830,088 (GRCm39) I159K probably damaging Het
Or56b1b G A 7: 108,164,402 (GRCm39) P200L probably benign Het
Pcdhb16 A T 18: 37,611,249 (GRCm39) K70* probably null Het
Pex5l T G 3: 33,061,327 (GRCm39) D174A probably benign Het
Plac8l1 A T 18: 42,313,460 (GRCm39) M94K probably benign Het
Plxna1 T C 6: 89,311,757 (GRCm39) probably benign Het
Psg26 T C 7: 18,208,996 (GRCm39) T471A probably benign Het
Pus3 C A 9: 35,477,968 (GRCm39) T400K probably benign Het
Pxk T C 14: 8,136,863 (GRCm38) probably benign Het
Rapgef2 T C 3: 78,996,057 (GRCm39) T569A probably benign Het
Sall4 T C 2: 168,597,964 (GRCm39) Q292R possibly damaging Het
Slc18b1 A G 10: 23,674,647 (GRCm39) D34G probably damaging Het
Slc45a1 T C 4: 150,722,517 (GRCm39) R456G probably damaging Het
Sox13 T C 1: 133,318,536 (GRCm39) R81G possibly damaging Het
Spag9 A G 11: 93,951,109 (GRCm39) probably benign Het
Ston1 C T 17: 88,942,788 (GRCm39) P65S probably damaging Het
Tada2b A T 5: 36,633,761 (GRCm39) D197E probably benign Het
Tcim T A 8: 24,928,765 (GRCm39) R50W probably damaging Het
Tnpo3 T C 6: 29,579,688 (GRCm39) D235G probably benign Het
Trim59 A G 3: 68,944,137 (GRCm39) V401A probably benign Het
Trpm3 A C 19: 22,425,741 (GRCm39) Q32P probably benign Het
Tubgcp5 T A 7: 55,480,614 (GRCm39) M1018K probably damaging Het
Ube2o A G 11: 116,437,689 (GRCm39) probably benign Het
Ugcg C T 4: 59,207,798 (GRCm39) P46S probably benign Het
Uvrag G T 7: 98,537,350 (GRCm39) S615* probably null Het
Vmn2r6 T A 3: 64,463,929 (GRCm39) I302L probably benign Het
Vmn2r73 C T 7: 85,521,198 (GRCm39) V257I probably benign Het
Other mutations in Brf2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL03371:Brf2 APN 8 27,615,872 (GRCm39) missense probably benign 0.11
R0179:Brf2 UTSW 8 27,615,896 (GRCm39) missense possibly damaging 0.73
R0615:Brf2 UTSW 8 27,614,059 (GRCm39) missense probably benign 0.00
R1066:Brf2 UTSW 8 27,613,974 (GRCm39) missense probably benign 0.34
R1882:Brf2 UTSW 8 27,618,577 (GRCm39) missense probably damaging 1.00
R5546:Brf2 UTSW 8 27,614,311 (GRCm39) missense possibly damaging 0.67
R5716:Brf2 UTSW 8 27,616,074 (GRCm39) missense probably benign
R6965:Brf2 UTSW 8 27,614,586 (GRCm39) missense probably benign 0.34
R7903:Brf2 UTSW 8 27,616,121 (GRCm39) missense possibly damaging 0.77
R7923:Brf2 UTSW 8 27,614,218 (GRCm39) nonsense probably null
R8184:Brf2 UTSW 8 27,614,013 (GRCm39) missense possibly damaging 0.81
R8282:Brf2 UTSW 8 27,614,621 (GRCm39) missense
R8365:Brf2 UTSW 8 27,618,566 (GRCm39) missense possibly damaging 0.91
R8704:Brf2 UTSW 8 27,618,499 (GRCm39) missense possibly damaging 0.84
R8848:Brf2 UTSW 8 27,616,140 (GRCm39) missense probably benign
R9293:Brf2 UTSW 8 27,614,021 (GRCm39) missense probably damaging 1.00
R9548:Brf2 UTSW 8 27,614,623 (GRCm39) missense probably benign 0.02
X0026:Brf2 UTSW 8 27,616,079 (GRCm39) missense probably benign
Z1088:Brf2 UTSW 8 27,614,019 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- ATGTGTTTCACCACCGACCG -3'
(R):5'- GGCACCGTGATCATTCATTCAC -3'

Sequencing Primer
(F):5'- CGACCGCTTGTTAAGTTTTAGAACC -3'
(R):5'- ACCGTGATCATTCATTCACTTGAC -3'
Posted On 2015-04-02